Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2016 1
2017 6
2018 2
2019 5
2020 9
2021 24
2022 16
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.
Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, Neuberger A, Ghanem-Zoubi N, Santoro A, Eliakim-Raz N, Pertzov B, Steinmetz T, Stern A, Dickstein Y, Maroun E, Zayyad H, Bishara J, Alon D, Edel Y, Goldberg E, Venturelli C, Mussini C, Leibovici L, Paul M; Bacteremia Duration Study Group. Yahav D, et al. Among authors: franceschini e. Clin Infect Dis. 2019 Sep 13;69(7):1091-1098. doi: 10.1093/cid/ciy1054. Clin Infect Dis. 2019. PMID: 30535100 Clinical Trial.
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab.
Franceschini E, Pellegrino M, Todisco V, Dolci G, Bettelli F, Meschiari M, Bedini A, Fregni-Serpini G, Grottola A, Guaraldi G, Pecorari M, Sarti M, Luppi M, Perno CF, Mussini C. Franceschini E, et al. Infection. 2023 Oct;51(5):1577-1581. doi: 10.1007/s15010-023-02039-2. Epub 2023 Apr 19. Infection. 2023. PMID: 37076752 Free PMC article.
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions.
Santacroce E, D'Angerio M, Ciobanu AL, Masini L, Lo Tartaro D, Coloretti I, Busani S, Rubio I, Meschiari M, Franceschini E, Mussini C, Girardis M, Gibellini L, Cossarizza A, De Biasi S. Santacroce E, et al. Among authors: franceschini e. Cells. 2024 Mar 2;13(5):439. doi: 10.3390/cells13050439. Cells. 2024. PMID: 38474403 Free PMC article. Review.
Hypokalemia in Patients with COVID-19.
Alfano G, Ferrari A, Fontana F, Perrone R, Mori G, Ascione E, Magistroni R, Venturi G, Pederzoli S, Margiotta G, Romeo M, Piccinini F, Franceschi G, Volpi S, Faltoni M, Ciusa G, Bacca E, Tutone M, Raimondi A, Menozzi M, Franceschini E, Cuomo G, Orlando G, Santoro A, Di Gaetano M, Puzzolante C, Carli F, Bedini A, Milic J, Meschiari M, Mussini C, Cappelli G, Guaraldi G; Modena Covid-19 Working Group (MoCo19). Alfano G, et al. Among authors: franceschini e. Clin Exp Nephrol. 2021 Apr;25(4):401-409. doi: 10.1007/s10157-020-01996-4. Epub 2021 Jan 4. Clin Exp Nephrol. 2021. PMID: 33398605 Free PMC article.
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections.
Gallerani A, Gatti M, Bedini A, Casolari S, Orlando G, Puzzolante C, Franceschini E, Menozzi M, Santoro A, Barp N, Volpi S, Soffritti A, Pea F, Mussini C, Meschiari M. Gallerani A, et al. Among authors: franceschini e. Antibiotics (Basel). 2023 Nov 19;12(11):1639. doi: 10.3390/antibiotics12111639. Antibiotics (Basel). 2023. PMID: 37998841 Free PMC article.
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review.
Barp N, Marcacci M, Biagioni E, Serio L, Busani S, Ventura P, Franceschini E, Orlando G, Venturelli C, Menozzi I, Tambassi M, Scaltriti E, Pongolini S, Sarti M, Pietrangelo A, Girardis M, Mussini C, Meschiari M. Barp N, et al. Among authors: franceschini e. Microorganisms. 2023 Apr 24;11(5):1112. doi: 10.3390/microorganisms11051112. Microorganisms. 2023. PMID: 37317086 Free PMC article. Review.
Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study.
Meschiari M, Kaleci S, Monte MD, Dessilani A, Santoro A, Scialpi F, Franceschini E, Orlando G, Cervo A, Monica M, Forghieri F, Venturelli C, Ricchizzi E, Chester J, Sarti M, Guaraldi G, Luppi M, Mussini C. Meschiari M, et al. Among authors: franceschini e. Antimicrob Resist Infect Control. 2023 Nov 13;12(1):126. doi: 10.1186/s13756-023-01332-x. Antimicrob Resist Infect Control. 2023. PMID: 37957773 Free PMC article.
Acid base disorders in patients with COVID-19.
Alfano G, Fontana F, Mori G, Giaroni F, Ferrari A, Giovanella S, Ligabue G, Ascione E, Cazzato S, Ballestri M, Di Gaetano M, Meschiari M, Menozzi M, Milic J, Andrea B, Franceschini E, Cuomo G, Magistroni R, Mussini C, Cappelli G, Guaraldi G; Modena Covid-19 Working Group (MoCo19). Alfano G, et al. Among authors: franceschini e. Int Urol Nephrol. 2022 Feb;54(2):405-410. doi: 10.1007/s11255-021-02855-1. Epub 2021 Jun 11. Int Urol Nephrol. 2022. PMID: 34115260 Free PMC article.
Efficacy of bezlotoxumab in preventing the recurrence of Clostridioides difficile infection: an Italian multicenter cohort study.
Meschiari M, Cozzi-Lepri A, Cervo A, Granata G, Rogati C, Franceschini E, Casolari S, Tatarelli P, Giacobbe DR, Bassetti M, Pinna SM, De Rosa FG, Barchiesi F, Canovari B, Lorusso C, Russo G, Cenderello G, Cascio A, Petrosillo N, Mussini C. Meschiari M, et al. Among authors: franceschini e. Int J Infect Dis. 2023 Jun;131:147-154. doi: 10.1016/j.ijid.2023.04.004. Epub 2023 Apr 7. Int J Infect Dis. 2023. PMID: 37030653 Free article.
78 results